Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
1995-2-3
pubmed:abstractText
Human skin fibroblasts were cultured in the presence of 4-methylumbelliferyl-beta-D-xyloside (Xyl-MU) using a mass-culture system with a microcarrier. The structures of Xyl-MU-induced sugars purified from the dialysable fraction of the incubation medium were investigated. In addition to glycosaminoglycans the elongation of which initiated by Xyl-MU has already been reported, and oligosaccharides similarly initiated by Xyl-MU, such as Gal-Gal-Xyl-MU, Gal-Xyl-MU and SA-Gal-Xyl-MU, a novel Xyl-MU-induced oligosaccharide was detected. This oligosaccharide was identified as GlcA beta 1-4Xyl beta 1-(4-methylumbelliferone) using sugar composition analysis, enzyme digestion, mass spectrometry and Smith degradation. Using this culture system, the amount of the new oligosaccharide produced increased with the incubation time, even after the production of glycosaminoglycan initiated by Xyl-MU and Gal-Xyl-MU had reached a plateau. These results suggest that this oligosaccharide may be involved in terminating the elongation of glycosaminoglycan chains that is initiated by Xyl-MU.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/7818474-1111597, http://linkedlifedata.com/resource/pubmed/commentcorrection/7818474-1156397, http://linkedlifedata.com/resource/pubmed/commentcorrection/7818474-1422137, http://linkedlifedata.com/resource/pubmed/commentcorrection/7818474-14272330, http://linkedlifedata.com/resource/pubmed/commentcorrection/7818474-1869505, http://linkedlifedata.com/resource/pubmed/commentcorrection/7818474-192724, http://linkedlifedata.com/resource/pubmed/commentcorrection/7818474-2104833, http://linkedlifedata.com/resource/pubmed/commentcorrection/7818474-2108135, http://linkedlifedata.com/resource/pubmed/commentcorrection/7818474-2126270, http://linkedlifedata.com/resource/pubmed/commentcorrection/7818474-2433270, http://linkedlifedata.com/resource/pubmed/commentcorrection/7818474-2515849, http://linkedlifedata.com/resource/pubmed/commentcorrection/7818474-3017944, http://linkedlifedata.com/resource/pubmed/commentcorrection/7818474-3109379, http://linkedlifedata.com/resource/pubmed/commentcorrection/7818474-3800933, http://linkedlifedata.com/resource/pubmed/commentcorrection/7818474-4372604, http://linkedlifedata.com/resource/pubmed/commentcorrection/7818474-4770369, http://linkedlifedata.com/resource/pubmed/commentcorrection/7818474-632301, http://linkedlifedata.com/resource/pubmed/commentcorrection/7818474-649611, http://linkedlifedata.com/resource/pubmed/commentcorrection/7818474-6626577, http://linkedlifedata.com/resource/pubmed/commentcorrection/7818474-7372638, http://linkedlifedata.com/resource/pubmed/commentcorrection/7818474-8420936
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0264-6021
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
304 ( Pt 3)
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
731-6
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1994
pubmed:articleTitle
A novel oligosaccharide, GlcA beta 1-4Xyl beta 1-(4-methylumbelliferone), synthesized by human cultured skin fibroblasts.
pubmed:affiliation
Department of Biochemistry, Hirosaki University School of Medicine, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't